Gedatolisib
Drug timelines are a Plus or Pro feature.
8 regulatory and trial events tracked for Gedatolisib, covering 2021-02-18 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: Gedatolisib in Combination With Darolutamide in Metastatic Castration-Resistant Prostate Cancer [Phase 1, Phase 2]